Laparoscopic staging of biliopancreatic malignancy.
Laparoscopic staging of biliopancreatic malignancy.
复制标题
胆胰恶性肿瘤的腹腔镜分期。
DOI：
10.1093/annonc/10.suppl_4.s33
复制
发表时间：
1999
期刊：
影响因子：
--
通讯作者：
H. Obertop
中科院分区：
文献类型：
--
作者：
D. Gouma;E. J. Nieveen van Dijkum;L. D. de Wit;H. Obertop
腹腔镜胆胰恶性肿瘤分期（LLU）的主要优点是可以检测到肝脏表面和腹膜的小浅表转移以及局部肿瘤向内生长。腹腔镜分期的不同方面已在文献中广泛描述，其益处通常表现为预防剖腹手术。这一最终分期程序对患者后续非手术姑息治疗疗效的影响很少进行分析。在这篇综述中，胆胰肿瘤的腹腔镜分期的结果，关于转移和肿瘤向内生长的检测，以及随后的非手术治疗后的长期随访结果和腹腔镜分期后的首选姑息治疗进行了讨论。
The main benefit of laparoscopic staging (LLU) of (distal) bilio-pancreatic malignancy is the detection of small superficial metastases at the liver surface and peritoneum and local tumor ingrowth. The different aspects of laparoscopic staging have been described extensively in the literature and the benefit is generally expressed in terms of prevention of laparotomy. The impact of this final staging procedure on outcome for the patient in terms of the efficacy of the subsequent non-surgical palliative treatment have been analysed scarsely. In this review the results of laparoscopic staging of bilio-pancreatic tumors concerning the detection of metastases and tumor ingrowth as well as the results of long term follow up after subsequent non-surgical treatment and the preferred palliative treatment after laparoscopic staging are discussed.